MUFG Americas’s BioSpecifics Technologies Corp. BSTC Stock Holding History

MUFG Americas’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40	Closed	-$2K	–	1060
2017 Q4	$2K	Sell	40 -26	-39%	-$1.17K	﹤0.01%	986
2017 Q3	$3K	Hold	66	–	–	﹤0.01%	1019
2017 Q2	$3K	Sell	66 -4	-6%	-$210	﹤0.01%	1022
2017 Q1	$4K	Hold	70	–	–	﹤0.01%	973
2016 Q4	$4K	Sell	70 -70	-50%	-$3.36K	﹤0.01%	966
2016 Q3	$6K	Sell	140 -70	-33%	-$2.81K	﹤0.01%	965
2016 Q2	$8K	Hold	210	–	–	﹤0.01%	924
2016 Q1	$7K	Sell	210 -140	-40%	-$5.14K	﹤0.01%	888
2015 Q4	$15K	Hold	350	–	–	﹤0.01%	761
2015 Q3	$15K	Sell	350 -510	-59%	-$27.5K	﹤0.01%	793
2015 Q2	$44K	Sell	860 -150	-15%	-$6.4K	﹤0.01%	637
2015 Q1	$40K	Buy	1,010 +210	+26%	+$8.23K	﹤0.01%	707
2014 Q4	$31K	Buy	800 +340	+74%	+$13K	﹤0.01%	751
2014 Q3	$16K	Buy	+460	New	+$13.5K	﹤0.01%	860

Other funds holding BSTC

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MUFG Americas's BSTC Position: Q1 2018 in Review

MUFG Americas sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2018, closing a stake of 40 shares — an estimated $2K sold.

MUFG Americas first reported a position in BSTC in Q3 2014 and held it in 14 quarters. The position peaked at $44K in Q2 2015. 78 funds tracked by Wall St. Rank hold BSTC as of Q1 2018.

MUFG Americas reported no remaining BioSpecifics Technologies Corp. position as of Q1 2018 after selling out during the quarter.
MUFG Americas sold 40 BioSpecifics Technologies Corp. shares in Q1 2018, an estimated $2K.
MUFG Americas first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 14 quarters.
MUFG Americas's BioSpecifics Technologies Corp. position peaked at $44K in Q2 2015.
78 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.